A combined 14.62 million shares have already changed hands on the counter till 1120 hours against an average sub 10 million shares that were traded daily in past two weeks.
The stock of medical equipment maker has tanked 52% in past seven trading sessions after reporting a sharp 94% year-on-year (yoy) drop in consolidated net profit at Rs 12.3 crore for the quarter ended March 2013 (Q4).
Its consolidated revenue too, fallen 33% to Rs 456 crore compared to Rs 681 crore in year ago quarter. Earnings before interest, taxes, depreciation, and amoritsation (EBITDA) crashed 64% to Rs 60 crore against 164 crore on yoy basis.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
